- Corning’s (NYSE:GLW) Optical Communications segment is experiencing significant growth, driven by the increasing demand for optical fiber from AI data centers.
- Analysts have issued positive price targets for Corning, with potential upsides of 10% to 15%, reflecting strong market confidence in the GLW stock outlook.
- Beyond AI, Corning’s solar business and Life Sciences division, particularly with its Velocity Vials product, are poised to contribute substantial future revenue, diversifying its growth prospects.
Corning (NYSE:GLW) is a leading materials science company specializing in glass, ceramics, and optical fiber. It operates in various sectors, including optical communications, display technologies, and life sciences. The GLW stock is currently trading at $197.93 per share, with a market capitalization of approximately $170.35 billion.
On June 5, 2026, UBS analyst Joshua Spector increased the price target for Corning to $228. This new target represents a potential upside of about 15.19% from the stock’s price when the target was published. This positive investment outlook is shared by other analyses, with one on Seeking Alpha suggesting a 10% to 15% upside.
This optimism is heavily driven by the artificial intelligence surge. As highlighted by Doug Nathman and his team at Trefis, power-hungry AI data centers require vast amounts of optical fiber to communicate. This demand fueled a 36% rise in sales for Corning’s Optical Communications segment in the most recent quarter.
The company’s stock performance reflects this strong demand. As noted by Zacks Investment Research, Corning shares have surged 126.6% in the last six months, outperforming the S&P 500. While it has underperformed competitor Ciena Corporation (NYSE:CIEN), it has outperformed Amphenol Corporation (NYSE:APH), showing strong relative growth in its sector.
Beyond AI, other divisions contribute to the positive growth forecast. The solar business is benefiting from U.S. tariffs and has secured customer commitments for 80% of its capacity over the next five years. Additionally, its Life Sciences division’s Velocity Vials product could generate between $1.5 billion and $3 billion in annual revenue, further diversifying Corning’s revenue streams.
